Skip to main content
. 2023 Jul 26;22:217. doi: 10.1186/s12936-023-04646-8

Fig. 1.

Fig. 1

A WAZ over follow-up time by any malaria exposure adjusted for infant age, infant sex, low birthweight, and an interaction term of infants age and malaria exposure (p = 0.21); B WAZ over follow-up time by asymptomatic P. falciparum infection exposure adjusted for infant age, infant sex, low birthweight, and an interaction term of infants age and malaria exposure (p = 0.34); C WAZ over follow-up time by clinical malaria exposure adjusted for infant age, infant sex, low birthweight, and an interaction term of infants age and malaria exposure (p = 0.08). The shaded area indicated 95% confidence intervals